1. Fosun International's CSA score increased to 72, above industry average. 2. Strong performance in ESG dimensions: 75 in Environmental, 72 in Social. 3. Included in S&P Global's Sustainability Yearbook 2025 top 1%. 4. Maintains MSCI ESG rating of AA and FTSE Russell ESG score. 5. Ongoing commitment to sustainability reflected in governance and management.
The rise in the CSA score and strong industry positioning can enhance investor confidence, reminiscent of similarly positive sustainability evaluations leading to price increases in comparable firms.
The article indicates substantial advancement in ESG performance, which is increasingly pivotal for investors and regulators, signaling potential growth for FOSUF.
Sustained improvements in ESG ratings often positively correlate with stock stability and investor interest over time, as seen in firms that prioritize sustainability.
HONG KONG, Oct. 8, 2025 /PRNewswire/ -- S&P Global recently released the 2025 Corporate Sustainability Assessment (CSA) score results for Fosun International Limited (HKEX stock code: 00656, "Fosun International" or "Fosun"). Fosun International's S&P Global CSA score has risen to 72 points, significantly outperforming the industry average and maintaining its leading position in the industry.
In the 2024 S&P Global CSA, Fosun International achieved an excellent score of 70, ranking in the top 5% of its global industry peers. This year, Fosun International's sustained and deepening commitment to sustainability was once again recognized, with its S&P Global CSA score rising to 72 points.
Fosun International demonstrated strong performance across all dimensions of this year's S&P Global CSA. It scored 75 in the Environmental dimension, 72 in the Social dimension, and 70 in the Governance and Economic dimension, fully reflecting its balanced development in Environmental, Social, and Governance (ESG) areas. Fosun International achieved outstanding results particularly in various sub-dimensions, including Energy, Water, Waste and Pollutants, Environmental Policy and Management, Business Ethics, Risk and Crisis Management, Customer Relations, and Human Capital Management.
Due to its ongoing commitment to ESG initiatives, Fosun International was once again included in the S&P Global's Sustainability Yearbook 2025 and was selected as the top 1% in S&P Global's Sustainability Yearbook 2025 (China Edition).
Fosun International has achieved significant milestones in global ESG ratings. As of now, Fosun International has maintained an MSCI ESG rating of AA. It received an HSI sustainability rating of AA- and has been included in the Hang Seng Corporate Sustainability Benchmark Index for consecutive years. Fosun also retained a leading FTSE Russell ESG score and continued to be selected as a constituent stock of the FTSE4Good Index Series.
Fosun International remains steadfast in its commitment to being a responsible global corporate citizen. It has established a robust ESG governance structure and management system, embedding sustainability principles across all levels of its operations.
In terms of green operations, Fosun International actively responds to China's carbon peaking and carbon neutrality goals by promoting carbon neutrality and energy conservation and emission reduction. Fosun International has published Climate Information Disclosures Reports for three consecutive years, demonstrating its commitment to global climate action. Fosun International has also established a Carbon Neutrality Committee and Working Group to guide and facilitate the implementation of carbon neutrality management across member companies.
Regarding social contribution, the Rural Doctors Program, launched in 2017, has supported 25,000 rural doctors and benefited 3 million rural families. The initiative, "Rural Doctors Program Empowering Rural Medical Services", was honored as one of the UNGC's "20 Cases of Private Sector's Sustainable Development in China for 20 Years". Fosun Pharma has consistently contributed the "China Solution" to the fight against malaria in Africa. As at the end of June 2025, its independently developed artesunate for injection had been used to treat more than 84 million patients with severe malaria worldwide. Additionally, Fosun Pharma had cumulatively supplied over 420 million doses of artesunate for injection globally.
Since its establishment, Fosun International has remained committed to its original aspirations of "Self-improvement, Teamwork, Performance, and Contribution to Society". Looking ahead, while continuing to focus on business operations, Fosun will further strengthen its sustainable development management, actively fulfill corporate social responsibilities, and advance ESG practices. Leveraging the resources and advantages of its global industrial ecosystem, Fosun strives to continuously create a better world.
About the S&P Global Corporate Sustainability Assessment
Launched in 1999, the S&P Global Corporate Sustainability Assessment (CSA) grades enterprises on how they put sustainability into practice, covering 61 different industry-specific ESG standards. Evaluating more than 7,000 companies each year, S&P Global CSA has become a reference tool for enterprises, helping them gauge the financial importance of a company's sustainability performance from the perspective of investors.
View original content:https://www.prnewswire.com/news-releases/fosun-internationals-sp-global-csa-score-rises-to-72-retains-industry-lead-302579136.html
SOURCE Fosun